De volta aos polimorfismos genéticos do EGF+61 e risco de câncer do pulmão

olhando para o futuro!

Autores

  • Ramon Andrade De Mello University of Porto

Downloads

Não há dados estatísticos.

Biografia do Autor

Ramon Andrade De Mello, University of Porto

MD. Medical Oncology Resident in the Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal; and Assistant Professor in the School of Medicine, Department of Medicine, University of Porto, Porto, Portugal.

Referências

Hu-Lieskovan S, Vallbohmer D, Zhang W, et al. EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients. Clin Cancer Res. 2011;17(15):5161-9.

Lim YJ, Kim JW, Song JY, et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett. 2005;374(3):157-60.

Kang HG, Choi JE, Lee WK, et al. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology. 2007;12(6):902-5.

de Mello RA, Ferreira M, Costa BM, et al. Association between +61 A/G polymorphism in the EGF gene and non-small cell lung cancer risk in male caucasians. Eur J Cancer. 2011;47(Suppl 1):S635. [poster 9139].

Zhang YM, Cao C, Liang K. Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis. Cancer Epidemiol. 2010;34(2):150-6.

Downloads

Publicado

2012-11-11

Como Citar

1.
Mello RAD. De volta aos polimorfismos genéticos do EGF+61 e risco de câncer do pulmão: olhando para o futuro!. Sao Paulo Med J [Internet]. 11º de novembro de 2012 [citado 15º de outubro de 2025];130(6):415-6. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/1514

Edição

Seção

Carta ao Editor